Scott L Burrows

CIK 1853327 · Chief Financial Officer · last filed 2026-06-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.82M

Companies

3

Total Filings

20

Lifetime Open-Market Net

-$3.02M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SYRE Chief Financial Officer 103,693 $80.79 $8.38M -$2.72M 10 2026-06-03
Spyre Therapeutics, Inc. (AGLE) Delisted Chief Financial Officer $12.01 $0 1 2023-09-05
ARQT Chief Financial Officer 59,115 $24.38 $1.44M -$298.6K 9 2023-03-08

Recent Filings · Page 2 of 2

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-09-05 Spyre Therapeutics, Inc. (AGLE) Delisted Grant (A) $0 EDGAR
2023-03-08 ARQT Sell (S) −291 -$4.4K EDGAR
2023-03-06 ARQT Grant (A) +21,000 $0 EDGAR
2023-03-02 ARQT Sell (S) −1,850 -$29.4K EDGAR
2022-09-20 ARQT Exer (M) +5,000 $8.4K EDGAR
2022-03-07 ARQT Mixed +12,997 -$5.1K EDGAR
2022-03-03 ARQT Sell (S) −420 -$7.5K EDGAR
2022-01-04 ARQT Grant (A) $0 EDGAR
2021-12-28 ARQT Sell (S) −12,560 -$252.1K EDGAR
2021-04-05 ARQT Grant (A) $0 EDGAR
Showing 1120 of 20
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.